INTERACTION OF PSA AND MRI SUSPICION SCORE ON THE CANCER DETECTION RATE OF MRI FUSION TARGETED BIOPSY

被引：0
|
作者：
Meng, Xiaosong
Rosenkrantz, Andrew B.
Mendhiratta, Neil
Guiffart, Pauline
Huang, Richard
Deng, Fang-Ming
Zhou, Ming
Melamed, Jonathan
Huang, William C.
Lepor, Herbert
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.516
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP53-19
引用
收藏
页码：E704 / E705
页数：2
相关论文
共 50 条
  • [31] CORRELATING MULTIPARAMETRIC PROSTATE MRI (MP-MRI) SUSPICION FOR PROSTATE CANCER WITH MRI/ULTRASOUND (MR/US) FUSION GUIDED BIOPSY RESULTS AND GLEASON GRADE
    Rais-Bahrami, Soroush
    Siddiqui, M. Minhaj
    Stamatakis, Lambros
    Vourganti, Srinivas
    Hoang, Anthony N.
    Walton-Diaz, Annerleim
    Logan, Jennifer
    Hong Truong
    Nix, Jeffrey
    Turkbey, Baris
    Choyke, Peter L.
    Wood, Bradford J.
    Pinto, Peter A.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E897 - E897
  • [32] Prostate MRI and transperineal TRUS/MRI fusion biopsy for prostate cancer detection: clinical practice updates
    Martorana, Eugenio
    Pirola, Giacomo Maria
    Aisa, Maria Cristina
    Scialpi, Pietro
    Di Blasi, Aldo
    Saredi, Giovanni
    D'Andrea, Alfredo
    Signore, Stefano
    Grisanti, Riccardo
    Scialpi, Michele
    TURKISH JOURNAL OF UROLOGY, 2019, 45 (04): : 237 - 244
  • [33] FOLLOW-UP OF MEN WITH MRI SUSPICION SCORE 4 OR 5 REGIONS OF INTEREST ON PROSTATE MRI AND NONMALIGNANT PATHOLOGIC FINDINGS ON INITIAL TARGETED PROSTATE BIOPSY
    Meng, Xiaosong
    Chao, Brian
    Chen, Fei
    Huang, Richard
    Deng, Fang-Ming
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1029 - E1029
  • [34] Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naive biopsy patients
    Zhang, Kai
    Zhang, Zhipeng
    Liu, Ming
    Zhu, Gang
    Roobol, Monique J.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (02) : 243 - 249
  • [35] Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance
    J P Radtke
    S Boxler
    T H Kuru
    M B Wolf
    C D Alt
    I V Popeneciu
    S Steinemann
    C Huettenbrink
    C Bergstraesser-Gasch
    T Klein
    C Kesch
    M Roethke
    N Becker
    W Roth
    H-P Schlemmer
    M Hohenfellner
    B A Hadaschik
    Prostate Cancer and Prostatic Diseases, 2015, 18 : 288 - 296
  • [36] Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer
    Drost, Frank-Jan H.
    Osses, Daniel F.
    Nieboer, Daan
    Steyerberg, Ewout W.
    Bangma, Chris H.
    Roobol, Monique J.
    Schoots, Ivo G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (04):
  • [37] Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naive patients: a retrospective cohort study
    Washino, Satoshi
    Kobayashi, Shigeru
    Okochi, Tomohisa
    Kameda, Tomohiro
    Konoshi, Tsuzumi
    Miyagawa, Tomoaki
    Takayama, Tatsuya
    Morita, Tatsuo
    BMC UROLOGY, 2018, 18
  • [38] Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance
    Radtke, J. P.
    Boxler, S.
    Kuru, T. H.
    Wolf, M. B.
    Alt, C. D.
    Popeneciu, I. V.
    Steinemann, S.
    Huettenbrink, C.
    Bergstraesser-Gasch, C.
    Klein, T.
    Kesch, C.
    Roethke, M.
    Becker, N.
    Roth, W.
    Schlemmer, H-P
    Hohenfellner, M.
    Hadaschik, B. A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (03) : 288 - 296
  • [39] Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naive biopsy patients
    Zhang, K.
    Zhang, Z.
    Zhu, G.
    Liu, M.
    Roobol, M.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 82 - 82
  • [40] What is the Best Method For Evaluating Gleason Score and Tumor Extent for MRI/US Fusion Targeted Biopsy?
    Gordetsky, Jennifer
    Schultz, Luciana
    Porter, Kristin
    Nix, Jeffrey
    Rais-Bahrami, Soroush
    LABORATORY INVESTIGATION, 2018, 98 : 346 - 346
12345